Literature DB >> 12610093

Bacillus anthracis.

R C Spencer1.   

Abstract

The events of 11 September 2001 and the subsequent anthrax outbreaks have shown that the West needs to be prepared for an increasing number of terrorist attacks, which may include the use of biological warfare. Bacillus anthracis has long been considered a potential biological warfare agent, and this review will discuss the history of its use as such. It will also cover the biology of this organism and the clinical features of the three disease forms that it can produce: cutaneous, gastrointestinal, and inhalation anthrax. In addition, treatment and vaccination strategies will be reviewed.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12610093      PMCID： PMC1769905          DOI： 10.1136/jcp.56.3.182

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


  54 in total

Review 1.  Anthrax: clinical features, pathogenesis, and potential biological warfare threat.

Authors:  A M Friedlander
Journal:  Curr Clin Top Infect Dis       Date:  2000

2.  Crystal structure of the anthrax lethal factor.

Authors:  A D Pannifer; T Y Wong; R Schwarzenbacher; M Renatus; C Petosa; J Bienkowska; D B Lacy; R J Collier; S Park; S H Leppla; P Hanna; R C Liddington
Journal:  Nature       Date:  2001-11-08       Impact factor: 49.962

3.  Human inhalation anthrax. A report of three fatal cases.

Authors:  W S ALBRINK; S M BROOKS; R E BIRON; M KOPEL
Journal:  Am J Pathol       Date:  1960-04       Impact factor: 4.307

Review 4.  Anthrax pathogenesis and host response.

Authors:  P Hanna
Journal:  Curr Top Microbiol Immunol       Date:  1998       Impact factor: 4.291

5.  Value of field data for extrapolation in anthrax.

Authors:  R E Lincoln; J S Walker; F Klein; A J Rosenwald; W I Jones
Journal:  Fed Proc       Date:  1967-09

6.  Survival of a patient with intestinal anthrax.

Authors:  D R Nalin; B Sultana; R Sahunja; A K Islam; M A Rahim; M Islam; B S Costa; N Mawla; W B Greenough
Journal:  Am J Med       Date:  1977-01       Impact factor: 4.965

7.  Evaluation of serologic tests for diagnosis of anthrax after an outbreak of cutaneous anthrax in Paraguay.

Authors:  L H Harrison; J W Ezzell; T G Abshire; S Kidd; A F Kaufmann
Journal:  J Infect Dis       Date:  1989-10       Impact factor: 5.226

8.  PCR analysis of tissue samples from the 1979 Sverdlovsk anthrax victims: the presence of multiple Bacillus anthracis strains in different victims.

Authors:  P J Jackson; M E Hugh-Jones; D M Adair; G Green; K K Hill; C R Kuske; L M Grinberg; F A Abramova; P Keim
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

9.  Sequence and organization of pXO1, the large Bacillus anthracis plasmid harboring the anthrax toxin genes.

Authors:  R T Okinaka; K Cloud; O Hampton; A R Hoffmaster; K K Hill; P Keim; T M Koehler; G Lamke; S Kumano; J Mahillon; D Manter; Y Martinez; D Ricke; R Svensson; P J Jackson
Journal:  J Bacteriol       Date:  1999-10       Impact factor: 3.490

10.  Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques.

Authors:  B E Ivins; M L Pitt; P F Fellows; J W Farchaus; G E Benner; D M Waag; S F Little; G W Anderson; P H Gibbs; A M Friedlander
Journal:  Vaccine       Date:  1998-07       Impact factor: 3.641
View more
  76 in total

1.  Variable lymphocyte receptor recognition of the immunodominant glycoprotein of Bacillus anthracis spores.

Authors:  Robert N Kirchdoerfer; Brantley R Herrin; Byung Woo Han; Charles L Turnbough; Max D Cooper; Ian A Wilson
Journal:  Structure       Date:  2012-03-07       Impact factor: 5.006

Review 2.  Exposing a killer: pathologists angle for anthrax.

Authors:  Stephen W Chensue
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

Review 3.  Bioterrorism and the Role of the Clinical Microbiology Laboratory.

Authors:  Elizabeth Wagar
Journal:  Clin Microbiol Rev       Date:  2016-01       Impact factor: 26.132

4.  X-ray structure of the ternary MTX.NADPH complex of the anthrax dihydrofolate reductase: a pharmacophore for dual-site inhibitor design.

Authors:  Brad C Bennett; Qun Wan; Md Faiz Ahmad; Paul Langan; Chris G Dealwis
Journal:  J Struct Biol       Date:  2009-05       Impact factor: 2.867

5.  Mechanisms of substrate selectivity for Bacillus anthracis thymidylate kinase.

Authors:  Cecilia Carnrot; Liya Wang; Dimitri Topalis; Staffan Eriksson
Journal:  Protein Sci       Date:  2008-06-03       Impact factor: 6.725

6.  Cell extract-containing medium for culture of intracellular fastidious bacteria.

Authors:  Sudhir Singh; Malgorzata Kowalczewska; Sophie Edouard; Carole Eldin; Céline Perreal; Pascal Weber; Said Azza; Didier Raoult
Journal:  J Clin Microbiol       Date:  2013-06-05       Impact factor: 5.948

7.  Anthrax: a continuing concern in the era of bioterrorism.

Authors:  Stefan Riedel
Journal:  Proc (Bayl Univ Med Cent)       Date:  2005-07

8.  Saccharides cross-reactive with Bacillus anthracis spore glycoprotein as an anthrax vaccine component.

Authors:  Joanna Kubler-Kielb; Evgeny Vinogradov; Haijing Hu; Stephen H Leppla; John B Robbins; Rachel Schneerson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-18       Impact factor: 11.205

9.  Identification of exosite-targeting inhibitors of anthrax lethal factor by high-throughput screening.

Authors:  Ludovic Bannwarth; Allison B Goldberg; Catherine Chen; Benjamin E Turk
Journal:  Chem Biol       Date:  2012-07-27

10.  Polymeric glycoconjugates protect and activate macrophages to promote killing of Bacillus cereus spores during phagocytosis.

Authors:  Olga Tarasenko; Elizabeth Burton; Lee Soderberg; Pierre Alusta
Journal:  Glycoconj J       Date:  2008-01-17       Impact factor: 2.916
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.